Please login to the form below

Not currently logged in
Email:
Password:

23andMe

This page shows the latest 23andMe news and features for those working in and with pharma, biotech and healthcare.

Healthcare’s voice revolution

Healthcare’s voice revolution

Google, by comparison, is reckoned to have backed in the region of 60 health-related companies via its GV (Google Ventures) arm (eg 23andMe and Doctor on Demand).

Latest news

More from news
Approximately 15 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Open minds for open innovation Open minds for open innovation

    In healthcare, programmes like 23andMe and PatientsLikeMe have demonstrated that this is a tangible tactic, despite the traditional need for high standards, strict regulation and rigorous process.

  • Pharma deals during January 2015 Pharma deals during January 2015

    Although not making the cut for our table, Genentech (Roche) closed a deal with 23andMe(the Google backed DNA screening test company) to use whole genome sequencing data to identify therapeutic

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • DiCE Molecules adds Dr Richard Scheller to its board of directors DiCE Molecules adds Dr Richard Scheller to its board of directors

    He currently serves as chief scientific officer at 23andMe. San Francisco-based DiCE Molecules has appointed Dr Richard Scheller to its board of directors. ... Dr Scheller brings nearly 20 years of leadership in drug discovery research and development to

  • 23andMe names privacy officer and corporate counsel 23andMe names privacy officer and corporate counsel

    Personal genetics firm 23andMe has appointed Kate Black as privacy officer and corporate counsel. ... While we have always had a team dedicated to this effort, we are thrilled to have Kate take a leadership role at 23andMe.”.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • The Eleven guide to NFTs The Eleven guide to NFTs

    Genetic data. The first of these could apply to the licensing of data provided by genetic researching sites such as 23andme - allowing users to monetise and profit from their health data.

  • Big data, privacy and the rise of genomic testing

    Now, organisations such as 23andMe are offering genetic testing and analysis to the public for less than £150, while BGI offers scientific grade Whole Genome Sequencing for as little as $600

  • What pharma needs to know about genomic data in 2016

    Partnerships between companies like the Human Longevity Inc. (HLI), Calico, 23andme, and the mean that we’ll start to see some innovative research and development work in this area.

  • 23andMe – is DNA screening ethical?

    23andMe, a personalised DNA service providing information and tools for individuals to learn about and explore their DNA, may be a solution. ... On average, a customer of 23andMe who consents to research contributes to over 230 studies.

  • Top 7 Trends in Pharma Marketing for 2015

    Indeed, early Jan 2015 news that  Genentech, a member of the Roche Group, are collaborating with 23andMe to analyse genomic data for Parkinson’s disease is proof of this.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...